
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
An underactive thyroid can be treated with levothyroxine. (hypothyroidism). The thyroid gland typically produces thyroid hormone, which it either replaces or increases. Low thyroid hormone levels can happen spontaneously, when the thyroid gland is damaged by radiation, drugs, or surgery, or when they are caused by another factor.
For regular mental and physical function to be maintained, thyroid hormone synthesis must be adequate. Enough thyroid hormone in toddlers is necessary for healthy mental and physical growth.Other forms of thyroid problems are also treated with this drug. (such as thyroid cancer).Infertility should not be treated with this drug unless it is brought on by insufficient thyroid hormone levels.
Additionally, it is used to treat myxedema coma, a severe case of hypothyroidism characterised by hypothermia and changes in mental state.It should be treated in the critical care unit with thyroid hormone replacement and aggressive treatment of individual organ system complications because it is a medical emergency with a high mortality rate.
Generic 25-g sublingual tablet of levothyroxine The dosage varies by age group, the patient's specific condition, body weight, and adherence to the diet and medicine.
The aetiology of hypothyroidism, body mass index, deiodinase activity (SPINA-GD), and sex are additional predictors of the necessary dose.After dosing has been set, annual or semi-annual clinical evaluations and TSH monitoring are necessary.
The Global Levothyroxine SodiumMarket accountedfor $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
The thyroid hormone thyroxine comes in a synthetic version called levothyroxine, also referred to as L-thyroxine. (T4).It is used to treat hypothyroidism, which includes the severe type known as myxedema coma of thyroid hormone deficiency.Certain varieties of thyroid tumours may also be prevented and treated with it.
Weight reduction is not recommended with it.Levothyroxine can be administered intravenously or orally.It may take up to six weeks for a dose to have its full impact.Weight loss, difficulty coping with heat, sweating, nervousness, trouble falling asleep, tremor, and a rapid heartbeat are all side effects of high doses.
In those who have recently experienced a cardiac attack, use is not advised. It has been determined that use during pregnancy is harmless.TSH and T4 levels in the blood should be regularly measured to determine the appropriate dose.
Levothyroxine is the medication of choice for hypothyroidism patients who frequently need lifetime thyroid hormone therapy. It is usually used to treat hypothyroidism. Through its capacity to reduce thyroid-stimulating hormone (TSH), which is thought to cause goitre, it may also be used to cure the condition.
In order to reduce TSH secretion in individuals with thyroid cancer or nodular thyroid disease, levothyroxine is also used as an interventional therapy.Even though TSH levels are in the normal range, a subset of hypothyroidism sufferers who are given the proper dose of levothyroxine will report ongoing symptoms.
Further laboratory and clinical testing is necessary for these individuals because they may have a different underlying reason for their symptoms.Additionally, because many medications can impact thyroid hormone levels, it's crucial to review their prescriptions and potential dietary supplements.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introdauction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in theIndustry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |